INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
13/11/2020
Voltar para busca
Dado oficial do USPTO
HYBRIGENICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079063980Classe
1, 5, 9, 35, 38, 42
Pedido
79063980
Registro
3731611
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
13/11/2020
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 35, 38, 42
Data de depósito
07/03/2008
Data de registro
29/12/2009
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/01/2020
Última transação
30/01/2020
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
PARIS, FR
Examinador
BLANE, SUZANNE
Unidade examinadora
M50
Descrição da marca
The mark consists of the wording "HYBRIGENCIS" in stylized font.
Titulares e representantes
Titulares
HYBRIGENICS SA
HYBRIGENICS SA
Representantes
Jeannine A Rittenhouse IpHorgan Ltd.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 35Classe 38Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biological materialsbiological reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays for scientific or medical research; proteins intended for producing protein for therapeutic useprotein arrays for scientific and medical research and therapeutic proteins for scientific use in drug discovery
Classe 5
Pharmaceuticalspharmaceutical preparations for the prevention and treatment of disorders of the immune systemthe cardiovascular systemthe metabolic systemgenito-urinary systemthe musculo-skeletal systemdermatologic systemalimentary tractsensory organsparasitic diseasesfor the treatment of inflammatory disorders for use in dermatologyoncologyhematology and in tissue and organ transplantation and for gastrointestinal disorders; chemico-pharmaceutical preparationsfor use in treatment of viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; pharmaceutical products used in the treatment of viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; antibioticsbiologicalbiochemical and biotechnological preparations for medical purposeschemical preparations for pharmaceutical purposes for the treatment of neurologicalinflammatoryimmunologicaldermatologicalviralinfectious diseasesinfectionsparasitescancerneurodegenerative diseasesobesitydiabetes; reagents in the nature of cultures of microorganisms for medical use; surgical tissuessurgical implants comprising living tissue
Classe 9
Computer programssoftware and software packagesall for the scientific analysis and research used in biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy; interface boards for computersapparatus for recordingtransmission and reproduction of sound; data processing and computer equipment in the nature of data processors and computersall the aforesaid goods being used in biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy
Classe 35
Subscription services to databases in the nature of subscription to electronic journals; database managementprovision of computer databases; all the aforesaid services being used in biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy
Classe 38
Telecommunicationstransmission of information via computer transmissiondigital networkselectronic communications networks; and the telecommunication networks; communications by computer terminals and by means of telecommunications in the nature of communication via analogue and digital computer terminals and by satellite; transmission of informationvia computer networks; communications and exchange of information on a telecommunications network; computer-assisted transmission of imagesdatamessages; providing multiple use access to global computer information networks for data dissemination over a telecommunications network; provision of access to databases by means of computer servers; communication by hypertext links over a telecommunications network and particularlythe Internet; providing e-mail services; data transmission servicesthe transmission of data into electronic directories and information transmission via telecommunications networksall the aforesaid services being used in biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy; information exchange services over a telecommunication networkinformation in the field of telecommunicationsradiotelegraphictelephonetelematic communicationsbroadcasting of information by the way of a database on the Internet in the pharmaceutical field; rental of access time to a database server; rental of access time to a computer for the handling of dataall these services being used in biologybioinformaticsbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy
Classe 42
Scientific and industrial research; the refinement of industrial processes and automationupdates of industrial process control; professional consultancy in the fields of industrial and scientific researchin biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomymaterials testinglaboratories in the nature of chemicalbiological and medical laboratoriescomputer programmingall the aforesaid services being used in biologybio-computingbiochemistrybiotechnologypharmaceuticalsproteomicsgenomicsthe cosmetics industry and agronomy; industrial and scientific research in the field of molecular biologyin genomicsproteomicsprotein screening and research of protein interactions
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
21/10/2020
INPC
INVALIDATION PROCESSED
21/10/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
30/09/2020
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
30/01/2020
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
30/01/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29/01/2020
ES71
TEAS SECTION 71 RECEIVED
11/12/2019
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
29/12/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/04/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
23/06/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/03/2017
XXCR
GENERIC MADRID TRANSACTION CREATED
04/03/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
28/09/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
28/01/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
28/01/2016
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
28/01/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
21/01/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
21/01/2016
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
21/01/2016
PR71
POST REGISTRATION ACTION MAILED - SEC.71
31/12/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/12/2015
ES71
TEAS SECTION 71 RECEIVED
18/11/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
18/05/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/04/2010
FIMP
FINAL DISPOSITION PROCESSED
26/04/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/03/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
29/12/2009
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/10/2009
PUBO
PUBLISHED FOR OPPOSITION
13/10/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/09/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/08/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/08/2009
ALIE
ASSIGNED TO LIE
25/08/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/08/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/07/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/07/2009
RFNT
REFUSAL PROCESSED BY IB
06/03/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/02/2009
RFRR
REFUSAL PROCESSED BY MPU
11/02/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/02/2009
CNRT
NON-FINAL ACTION WRITTEN
10/02/2009
MAFR
APPLICATION FILING RECEIPT MAILED
03/02/2009
DOCK
ASSIGNED TO EXAMINER
30/01/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/01/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/01/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HYBRIGENICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.